Pharmacology of the selective 5-HT(1B/1D) agonist frovatriptan (Q44004694)

28 November 2017

title

Pharmacology of the selective 5-HT(1B/1D) agonist frovatriptan (English)

1 reference

28 November 2017

1 reference

Comer MB

1

1 reference

28 November 2017

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

42 Suppl 2

1 reference

28 November 2017

page(s)

S47-53

1 reference

Prevalence and impact of migraine

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Diagnosis and management of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Effects of the novel antimigraine agent, frovatriptan, on coronary and cardiac function in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.2.X

10.1046/J.1526-4610.42.S2.2.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference